Researchers have developed a new genetic test that can determine whether breast cancer patients can avoid chemotherapy. Putting the test to work, researchers found that most women with early-stage breast cancer may be able to skip the treatment, although the same does not necessarily apply to those who have larger tumors or those with cancer that has started to spread. Of the more than 250,000 women in the US expected to be diagnosed with breast cancer, the new findings could benefit more than 63,000 with non-invasive, or early stage breast cancer.
New genetic test may save thousands of women from going through chemotherapy
More of Today's Solutions
Vision board ideas for adults: how to create one that inspires real change
BY THE OPTIMIST DAILY EDITORIAL TEAM A vision board might look like a crafty throwback to childhood afternoons spent collaging. But don’t write it ...
Read MoreIndia’s social experiment: how paying women directly reshapes welfare, autono...
BY THE OPTIMIST DAILY EDITORIAL TEAM Across India, millions of women now receive a modest but unwavering deposit each month into their bank accounts. ...
Read MoreNew Zealand’s groundbreaking shift to renewables promises massive emiss...
New Zealand launched its most ambitious emissions reduction initiative to date in an incredible undertaking. The government announced a historic switch from coal to ...
Read MoreGoing for the goal: the impact of team sports on boosting young girls’ ...
In a pioneering study, the Here for Every Goal report demonstrates that team sports, particularly elite women's soccer (referenced from here on in this ...
Read More
